{
    "componentChunkName": "component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-timeline-templates-post-query-js",
    "path": "/ja/tweet/1478044742885777410/",
    "result": {"data":{"site":{"siteMetadata":{"title":"经济学人","author":"Buzzing.cc","description":"用中文浏览经济学人","keywords":["buzzing","经济学人"],"siteUrl":"https://economist.buzzing.cc","telegram":"@buzzingcc","iconUrl":"https://economist.buzzing.cc/avatar.jpg","defaultSocialImageUrl":"https://images.unsplash.com/photo-1624129591276-5b11185e7b42?ixid=MnwxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8&ixlib=rb-1.2.1&auto=format&fit=crop&w=2739&q=80","social":[{"name":"The Economist","url":"https://www.economist.com/","external":true},{"name":"Twitter @TheEconomist","url":"https://twitter.com/TheEconomist","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"RSS","url":"/rss.xml","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on The Economist","description":"See what's buzzing on The Economist in your native language","keywords":["buzzing","The Economist"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"RSS","url":"/en/rss.xml","external":null}]},{"title":"經濟學人","description":"用中文瀏覽經濟學人","keywords":["buzzing","經濟學人"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"RSS","url":"/zh-Hant/rss.xml","external":null}]},{"title":"エコノミスト人気の記事","description":"人気のエコノミスト記事を日本語で閲覧","keywords":["buzzing","エコノミスト"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"TweetPost-1478044742885777410","excerpt":"","body":"","slug":"/tweet/1478044742885777410/","title":"“We believe that in 15 years, one-third of all newly approved drugs will be based on mRNA,” say the founders of @BioNTech_Group in The #WorldAhead 2022 https://t.co/REMyvvJ2dH","tags":["WorldAhead","tweet"],"date":"January 04, 2022","dateISO":"2022-01-04T12:50:42.000Z","datetime":"2022-01-04 12:50","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"1478044742885777410","provider":"Twitter","url":"https://twitter.com/TheEconomist/statuses/1478044742885777410","originalUrl":null,"imageRemote":null,"video":null,"channel":null,"channelUrl":null,"author":"The Economist","authorUrl":"https://twitter.com/TheEconomist","authorImage":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-.jpg","authorSlug":"TheEconomist","score":151,"views":null,"sharedCount":32,"likeCount":87,"sharedContent":null,"parent":{"localize":[{"locale":"ja","full_text":"\"15年後には、新たに承認される医薬品の3分の1がmRNAに基づくものになると考えています。\" @BioNTech_Group の創業者は、The #WorldAhead 2022 https://t.co/REMyvvJ2dH で次のように述べています。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"\"我们相信，15年后，所有新批准的药物中有三分之一将基于mRNA，\"@BioNTech_Group的创始人在#WorldAhead 2022 https://t.co/REMyvvJ2dH 中说。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"\"我們相信，15年後，所有新批准的藥物中有三分之一將基於mRNA，\"@BioNTech_Group的創始人在#WorldAhead 2022 https://t.co/REMyvvJ2dH 中說。","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"previous":{"id":"TweetPost-1478272409237086208","excerpt":"","slug":"/tweet/1478272409237086208/","title":"Iceland’s experience suggests a better balance between work and life need not reduce output https://t.co/do4BOHrGrd","date":"January 04, 2022","__typename":"SocialMediaPost","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"アイスランドの経験から、仕事と生活のバランスを良くすることは、生産量を減らす必要はないことがわかった https://t.co/do4BOHrGrd","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"冰岛的经验表明，更好地平衡工作和生活并不需要减少产出https://t.co/do4BOHrGrd。","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"冰島的經驗表明，更好地平衡工作和生活並不需要減少產出https://t.co/do4BOHrGrd。","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"TweetPost-1478161464233971713","excerpt":"","slug":"/tweet/1478161464233971713/","title":"After four years as a trans man, Carol became a “detransitioner”: someone who has taken cross-sex hormones or had surgery, or both, before realising this was a mistake. This is her story https://t.co/6uyfDbwWgn","__typename":"SocialMediaPost","date":"January 04, 2022","provider":"Twitter","parent":{"localize":[{"locale":"ja","full_text":"キャロルは、トランス男性として4年過ごした後、「デトランジスター」（異性間ホルモン剤の服用や手術、あるいはその両方）になり、それが誤りであったことに気づきました。これは、彼女のストーリーです。https://t.co/6uyfDbwWgn","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh","full_text":"在当了四年的变性人之后，卡罗尔成为了一名 \"脱变者\"：在意识到这是一个错误之前，已经服用了跨性别激素或做了手术，或两者都做了。这是她的故事 https://t.co/6uyfDbwWgn","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"在當了四年的變性人之後，卡羅爾成爲了一名 \"脫變者\"：在意識到這是一個錯誤之前，已經服用了跨性別激素或做了手術，或兩者都做了。這是她的故事 https://t.co/6uyfDbwWgn","quoted_status_full_text":null,"retweeted_status_full_text":null}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"TweetPost-1478044742885777410","previousId":"TweetPost-1478272409237086208","nextId":"TweetPost-1478161464233971713","maxWidth":1024,"siteMetadata":{"siteUrl":"https://economist.buzzing.cc","author":"Buzzing.cc","locale":"zh","title":"经济学人","shortTitle":"经济学人","description":"用中文浏览经济学人","keywords":["buzzing","经济学人"],"telegram":"@buzzingcc","telegram_chat_id":"-1001406368978","iconUrl":"https://economist.buzzing.cc/avatar.jpg","menuLinks":[{"name":"RSS","url":"/rss.xml","prefetch":false}],"subscriptions":[{"name":"Twitter @buzzingcc","url":"https://twitter.com/buzzingcc","external":true},{"name":"Telegram @buzzingcc","url":"https://t.me/buzzingcc","external":true},{"name":"RSS","url":"/rss.xml","prefetch":false}],"social":[{"name":"The Economist","url":"https://www.economist.com/","external":true},{"name":"Twitter @TheEconomist","url":"https://twitter.com/TheEconomist","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"localize":[{"locale":"en","title":"Buzzing on The Economist","shortTitle":"BuzzEconomist","description":"See what's buzzing on The Economist in your native language","keywords":["buzzing","The Economist"],"menuLinks":[{"name":"RSS","url":"/en/rss.xml","prefetch":false}]},{"locale":"zh-Hant","title":"經濟學人","shortTitle":"經濟學人","description":"用中文瀏覽經濟學人","keywords":["buzzing","經濟學人"],"menuLinks":[{"name":"RSS","url":"/zh-Hant/rss.xml","prefetch":false}]},{"locale":"ja","title":"エコノミスト人気の記事","shortTitle":"エコノミスト","description":"人気のエコノミスト記事を日本語で閲覧","keywords":["buzzing","エコノミスト"],"menuLinks":[]}],"defaultSocialImageUrl":"https://images.unsplash.com/photo-1624129591276-5b11185e7b42?ixid=MnwxMjA3fDB8MHxwaG90by1wYWdlfHx8fGVufDB8fHx8&ixlib=rb-1.2.1&auto=format&fit=crop&w=2739&q=80"},"locale":"ja","hrefLang":"ja-JA","originalPath":"/tweet/1478044742885777410/","dateFormat":"YYYY-MM-DD"}},
    "staticQueryHashes": ["1239077767","2744905544","3280999885"]}